Table 3.
Parameter | Research Date | |||
---|---|---|---|---|
Before the Start of the Study (before WBC) | After WBC | After Exercise Preceded by WBC (WBC Exercise) | After Exercise without WBC (Control Exercise) | |
Mean ± SD | ||||
CK (IU/L) | 204.9 ± 96.74 | 181.4 ± 89.37 | 203.4 ± 82.17 | 233.8 ± 79.96 |
IL-1β (pg/mL) | 6.72 ± 3.26 | 6.87 ± 2.65 | 4.83 ± 1.91 | 9.93 ± 3.73 aa bb ccc |
TNF-α (pg/mL) | 10.93 ± 5.29 | 10.08 ± 5.24 | 7.78 ± 2.47 | 10.63 ± 4.58 |
IL-6 (pg/mL) | 4.75 ± 2.36 | 2.27 ± 1.05 aa | 4.42 ± 1.01 b | 5.95 ± 2.45 bbb |
TGF-β1 (ng/mL) | 31.23 ± 15.61 | 34.37 ± 14.65 | 33.59 ± 16.05 | 37.39 ± 13.39 |
a Statistically significant difference compared with the concentration measured before WBC (aa p < 0.01); b statistically significant difference compared with the concentration measured after WBC (bbb p < 0.001; bb p < 0.01; b p < 0.05); c statistically significant difference compared with the concentration measured after the exercise associated with WBC (ccc p < 0.001).